Reveal Genomics’ first goal will be to develop diagnostic tools based on complex genomic data for patients with advanced breast cancer.
In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1
Today the results of the phase 2 CORALLEEN clinical trial, promoted by the international academic group SOLTI, have been presented. The study, publis1
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the co1
The latest advance in the field of immune therapies against cancer are the active and targeted CAR therapies. This treatment consists of obtaining th1
